Investing NewsNovo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss Drugs, AgainOctober 13, 2023 by admin 0 Comments Novo Nordisk raised its full-year outlook again as demand soars for its Ozempic and Wegovy weight-loss treatments. Articles You May Like Dump These 3 Stock Duds Before the Market Mayhem Intensifies Betting on Reddit Stock: Should You Join the Bulls or Heed the Bears’ Warning? Is Gold the New Bitcoin? 3 Stocks to Ride This Potential Boom 3 Hydrogen Stocks to Buy on the Dip: April 2024 Exploring Different Types of Homes and What They Costs